Research Summary

Mental disorders, such as depression and schizophrenia, still lack clear objective measurable indicators. However, over the past sixty years, a huge number of researchers have been developing many types of methods and variations of medications. 
It is very important to investigate the multiple factors that correlate with the response to medication and the effectiveness of treatments.
Thus, in our department, the main research aim has been to combine clinical factors and biomarkers, some of which are genetic polymorphism, quantitative electroencephalogram, and neuroprotective factors, taking into account the effectiveness of treatment, in order to provide an individualized strategy, known as personalized medicine.
For this purpose, we have established international collaborative and exchange relations with Bern University , Zurich University (Switzerland), Bologna University (Italy), Harvard (USA), and Karolinska Institute (Sweden).